- Home
- WFF vs CANF Comparison
WFF vs CANF Comparison
Compare WFF & CANF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | WFF | CANF |
|---|---|---|
| Founded | 1984 | 1994 |
| Country | Malaysia | Israel |
| Employees | 138 | N/A |
| Industry | Miscellaneous manufacturing industries | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.9M | 7.2M |
| IPO Year | N/A | 2011 |
Fundamental Metrics
Financial Performance| Metric | WFF | CANF |
|---|---|---|
| Price | $1.83 | $3.42 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $50.00 |
| AVG Volume (30 Days) | 11.6K | ★ 942.3K |
| Earning Date | 05-24-2026 | 03-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $2,715,455.50 |
| Revenue Next Year | N/A | $101.06 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.18 | $0.17 |
| 52 Week High | $29.22 | $10.40 |
Technical Indicators
Market Signals| Indicator | WFF | CANF |
|---|---|---|
| Relative Strength Index (RSI) | 69.07 | 52.84 |
| Support Level | $0.40 | $2.89 |
| Resistance Level | N/A | $4.74 |
| Average True Range (ATR) | 0.10 | 0.37 |
| MACD | 0.01 | 0.04 |
| Stochastic Oscillator | 67.53 | 47.20 |
Price Performance
Historical ComparisonAbout WFF WF Holding Limited Ordinary Shares
WF Holding Ltd is a manufacturer of FRP products based in Malaysia. It has been providing high-quality and durable FRP products to various industries, including, among others, chemical processing, water and wastewater treatment, and power generation. Its products range from tanks, pipes, ducts, gratings and other custom-made FRP products. The company uses advanced production technology and equipment and has obtained various certifications. Its manufacturing capabilities allow the company to design and fabricate products that meet the specific needs of its clients, ensuring high-quality and reliable performance.
About CANF Can-Fite Biopharma Ltd Sponsored ADR (Israel)
Can Fite Biopharma Ltd is a clinical-stage biopharmaceutical company. The company focuses on developing orally bioavailable small-molecule drugs targeting the A3 adenosine receptor for treating cancer, inflammatory diseases, liver disorders, and related conditions. It has a pipeline of proprietary drug candidates in Phase II and Phase III clinical development. The company's platform targets the A3 adenosine receptor (A3AR), which is more expressed in inflammatory and cancerous cells than in normal cells. Its pipeline drugs include Namodenoson, Piclidenoson, CF602, and Cannabinoids.